BNR logo

BNR

Profile

Full Name

Burning Rock Biotech Limited

Ticker Symbol

BNR

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

China

IPO

June 12, 2020

Indexes

Not included

Website

http://www.brbiotech.com

Employees

786

Key Details

Price

$2.90(-1.36%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$71.89M(-5.38% YoY)

Annual EPS

-$4.70(+47.93% YoY)

PE ratio

-

Next earnings date

May 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.90
BNR price is $2.90

30-Day Relative Volume

1.00
BNR 30-day relative volume is 1.00

Price Performance

Price Most recent change

-1.36%
BNR price was down -1.36% on Apr 16, 2025

Price YTD change

-57.04%
BNR price is down -57.04% since January 1st

Price 1-year change

-61.84%
BNR price is down -61.84% year-on-year

Price 3-year change

-95.99%
BNR price is down -95.99% over the past 3 years

Price Range

Price All-time high

$397.50
BNR price is currently -99.27% below its historical high of $397.50

Price 3-year low

$2.62
BNR price is currently +10.69% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$29.75M
BNR market capitalization is $29.75 million

Market cap 3-year change

-96.09%
BNR market capitalization is down -96.09% over the past 3 years

Market cap All-time high

$4.14B
BNR market capitalization is currently -99.28% below its historical high of $4.14 billion

Market cap sector rank

31.66%
BNR market capitalization is higher than 31.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
BNR {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-2.47%
BNR shares outstanding is down -2.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
BNR beta is 0.76

200-day SMA

$5.36
BNR price is currently -45.86% below its 200-day simple moving average

50-day SMA

$5.34
BNR price is currently -45.64% below its 50-day simple moving average

RSI

20.09
BNR 14-day relative strength index is 20.09

Volume

1.00
BNR 30-day relative volume is 1.00

ATR

$0.32
BNR average true range is $0.32

10-day Historical Volatility

51.11%
BNR 10-day historical volatility is 51.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$71.89M
BNR annual revenue is $71.89 million

Revenue Analysts estimate

$166.13M
BNR annual revenue is currently -56.73% lower than the consensus analysts' forecast

Revenue 1-year change

-5.38%
BNR annual revenue is down -5.38% year-on-year

Revenue Sector rank

52.07%
BNR annual revenue is higher than 52.07% of companies in Healthcare sector

EPS

EPS

-$4.70
BNR annual earnings per share is -$4.70

EPS Analysts estimate

-
BNR annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+47.93%
BNR annual earnings per share is up +47.93% year-on-year

EPS Sector rank

20.41%
BNR annual earnings per share is higher than 20.41% of companies in Healthcare sector

Profit

Gross profit

$50.51M
BNR annual gross profit is $50.51 million

Gross margin

70.26%
BNR annual gross profit margin is 70.26%

Operating profit

-$44.94M
BNR annual operating income is -$44.94 million

Operating margin

-62.51%
BNR annual operating profit margin is -62.51%

Net income

-$48.31M
BNR annual net profit is -$48.31 million

Net margin

-67.20%
BNR annual net profit margin is -67.20%

Expenses

Total expenses

$116.82M
BNR annual total expenses is $116.82 million

Operating expenses

$95.44M
BNR annual total operating expenses is $95.44 million

Cost of goods sold

$21.38M
BNR annual cost of goods sold is $21.38 million

Selling, general & administrative expenses

$63.07M
BNR annual SGA is $63.07 million

Depreciation and amortization

-
BNR annual depreciation & amortization value is unknown

Interest expense

-
BNR annual interest expense value is unknown

Income tax

$820.20K
BNR annual income tax is $820.20 thousand

EBIT & EBITDA

EBIT

-$44.94M
BNR annual earnings before interest & taxes is -$44.94 million

EBITDA

-$44.94M
BNR annual EBITDA is -$44.94 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$121.27M
BNR annual total assets is $121.27 million

Non current assets

$14.89M
BNR annual long term assets is $14.89 million

Current assets

$106.38M
BNR annual total current assets is $106.38 million

Cash and cash equivalents

$71.21M
BNR annual cash & cash equivalents is $71.21 million

Accounts receivable

$20.82M
BNR annual accounts receivable is $20.82 million

Inventory

$8.58M
BNR annual inventory is $8.58 million

Liabilities

Total liabilities

$41.71M
BNR annual total liabilities is $41.71 million

Long term liabilities

$5.23M
BNR annual total long term liabilities is $5.23 million

Current liabilities

$36.48M
BNR annual total current liabilities is $36.48 million

Accounts payable

$4.62M
BNR annual accounts payable is $4.62 million

Debt

Total debt

$7.17M
BNR annual total debt is $7.17 million

Total debt 1-year change

+312.24%
BNR annual total debt is up +312.24% year-on-year

Long term debt

$3.80M
BNR annual long term debt is $3.80 million

Short term debt

$3.37M
BNR annual short term debt is $3.37 million

Equity & Capital

Shareholders equity

$79.56M
BNR annual stockholders equity is $79.56 million

Book value

$79.56M
BNR annual book value is $79.56 million

Retained earnings

-$575.37M
BNR annual retained earnings is -$575.37 million

Working capital

$69.91M
BNR annual working capital is $69.91 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.86M
BNR annual cash flow from operations is -$12.86 million

Cash from operations 1-year change

+64.44%
BNR annual cash flow from operations is up +64.44% year-on-year

Cash from investing

-$614.90K
BNR annual cash flow from investing activities is -$614.90 thousand

Cash from investing 1-year change

+53.23%
BNR annual cash flow from investing activities is up +53.23% year-on-year

Cash from financing

-$10.00K
BNR annual cash flow from financing activities is -$10.00 thousand

Cash from financing 1-year change

+99.86%
BNR annual cash flow from financing activities is up +99.86% year-on-year

CAPEX

CAPEX

-
BNR annual capital expenditures value is unknown

CAPEX 1-year change

-
BNR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.86M
BNR annual free cash flow is -$12.86 million

Free cash flow 1-year change

+65.7%
BNR annual free cash flow is up +65.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

70.26%
BNR annual gross profit margin is 70.26%

Operating margin

-62.51%
BNR annual operating profit margin is -62.51%

Net margin

-67.20%
BNR annual net profit margin is -67.20%

ROA & ROE

ROA

-36.05%
BNR annual return on assets is -36.05%

ROE

-51.40%
BNR annual return on equity is -51.40%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BNR price to earnings ratio value is unknown

PE ratio Sector rank

-
BNR price to earnings ratio is unknown

PB Ratio

PB ratio

0.37
BNR price to book ratio is 0.37

PB ratio Sector rank

26.09%
BNR price to book ratio is higher than 26.09% of companies in Healthcare sector

PS Ratio

PS ratio

0.41
BNR price to sales ratio is 0.41

PS ratio Sector rank

14.62%
BNR price to sales ratio is higher than 14.62% of companies in Healthcare sector

Enterprise value

Enterprise value

-$34.29M
BNR enterprise value is -$34.29 million

Enterprise value Sector rank

2.4%
BNR enterprise value is higher than 2.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.76
BNR EV/EBITDA is 0.76

EV/EBITDA Sector rank

73.89%
BNR EV/EBITDA is higher than 73.89% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.92
BNR annual current ratio is 2.92

Quick ratio

2.68
BNR annual quick ratio is 2.68

Leverage

Debt to equity

0.00
BNR annual debt to equity ratio is 0.00

Interest coverage ratio

-
BNR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
BNR piotroski f-score is 4

Altman Z-Score

-6.15
BNR altman z-score is -6.15

Analyst ratings

Recent major analysts updates

Jul 14, 21 CICC
Outperform
Jul 13, 20 B of A Securities
Buy
Jul 7, 20 Cowen & Co.
Outperform

Institutional Ownership

Similar stocks

KZR logo
Kezar Life Sciences (KZR)
ALXO logo
ALX Oncology Holdings (ALXO)
CASI logo
CASI Pharmaceuticals (CASI)
FEMY logo
Femasys (FEMY)
ESLA logo
Estrella Immunopharma (ESLA)
BOLD logo
Boundless Bio (BOLD)
ALLK logo
Allakos (ALLK)
DRIO logo
DarioHealth (DRIO)
Cadrenal Therapeutics (CVKD)
  • What is the ticker symbol for Burning Rock Biotech Limited?
  • Does Burning Rock Biotech Limited pay dividends?
  • What sector is Burning Rock Biotech Limited in?
  • What industry is Burning Rock Biotech Limited in?
  • What country is Burning Rock Biotech Limited based in?
  • When did Burning Rock Biotech Limited go public?
  • Is Burning Rock Biotech Limited in the S&P 500?
  • Is Burning Rock Biotech Limited in the NASDAQ 100?
  • Is Burning Rock Biotech Limited in the Dow Jones?
  • When was Burning Rock Biotech Limited's last earnings report?
  • When does Burning Rock Biotech Limited report earnings?

What is the ticker symbol for Burning Rock Biotech Limited?

The ticker symbol for Burning Rock Biotech Limited is NASDAQ:BNR

Does Burning Rock Biotech Limited pay dividends?

No, Burning Rock Biotech Limited does not pay dividends

What sector is Burning Rock Biotech Limited in?

Burning Rock Biotech Limited is in the Healthcare sector

What industry is Burning Rock Biotech Limited in?

Burning Rock Biotech Limited is in the Diagnostics & Research industry

What country is Burning Rock Biotech Limited based in?

Burning Rock Biotech Limited is headquartered in China

When did Burning Rock Biotech Limited go public?

Burning Rock Biotech Limited's initial public offering (IPO) was on June 12, 2020

Is Burning Rock Biotech Limited in the S&P 500?

No, Burning Rock Biotech Limited is not included in the S&P 500 index

Is Burning Rock Biotech Limited in the NASDAQ 100?

No, Burning Rock Biotech Limited is not included in the NASDAQ 100 index

Is Burning Rock Biotech Limited in the Dow Jones?

No, Burning Rock Biotech Limited is not included in the Dow Jones index

When was Burning Rock Biotech Limited's last earnings report?

Burning Rock Biotech Limited's most recent earnings report was on Mar 25, 2025

When does Burning Rock Biotech Limited report earnings?

The next expected earnings date for Burning Rock Biotech Limited is May 29, 2025
On this page